ConductScience.org, home

Trial · NCT01508325

Outcomes12

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange From Baseline in Mean Ambulatory Diastolic Blood Pressure (DBP) in the Last 4 Hours After 12-week TreatmentBaseline and Week 12ITT analysis population included all the randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectivelymmHgMEAN
PRIMARYChange From Baseline in Mean Heart Rate in the Last 4 Hours After 12-week TreatmentBaseline and Week 12ITT analysis population included all randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectively.beats/minMEAN
SECONDARYChange From Baseline in Mean Ambulatory Systolic Blood Pressure (SBP) in the Last 4 Hours After 12-week TreatmentBaseline and Week 12ITT analysis population included all randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectively.mmHgMEAN
SECONDARYChange From Baseline in Mean Ambulatory 24-hour Blood Pressure at Week 12Baseline and Week 12ITT analysis population included all randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectively.mmHgMEAN
SECONDARYChange From Baseline in Mean Ambulatory Daytime Blood Pressure at Week 12Baseline and Week 12ITT analysis population included all randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectively.mmHgMEAN
SECONDARYChange From Baseline in Mean Ambulatory Night-time Blood Pressure at Week 12Baseline and Week 12ITT analysis population included all randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectively.mmHgMEAN
SECONDARYChange From Baseline in Mean Ambulatory Daytime Heart Rate at Week 12Baseline and Week 12ITT analysis population included all randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectively.beats/minMEAN
SECONDARYChange From Baseline in Mean Ambulatory Night-time Heart Rate at Week 12Baseline and Week 12ITT analysis population included all randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectively.beats/minMEAN
SECONDARYChange From Baseline in 24-hour Blood Pressure Variability at Week 12Baseline and Week 12ITT analysis population included all randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectively.mmHgMEAN
SECONDARYBlood Pressure Response RateWeek 12ITT analysis population included all randomized subjects. 'N' (number of subjects analyzed) signifies number of evaluable subjects for this outcome measure.percentage of subjectsNUMBER
SECONDARYHeart Rate Response RateWeek 12ITT analysis population included all randomized subjects. 'N' (number of subjects analyzed) signifies number of evaluable subjects for this outcome measure.percentage of subjectsNUMBER
SECONDARYChange From Baseline in Mean Ambulatory 24-hour Heart Rate at Week 12Baseline and Week 12ITT analysis population included all randomized subjects. 'n' signifies number of subjects evaluable for this outcome measure at given timepoints for each group, respectively.beats/minMEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01508325/outcomes